BridgeMD
New treatment option for Peripheral Artery Disease (PAD)
Official title Detecting Peripheral Artery Disease With the Pulse
ClinicalTrials.gov ID: NCT07226193
What this study is testing
- What it's testing
- 1) The purpose of this study is to assess segmental pulse arrival time (PAT) as an alternative biomarker to detect lower-extremity peripheral artery disease (PAD), and to investigate the impacts of local skin heating and foot elevation. The secondary purpose will be to investigate the impacts of age on segmental PAT.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older. Healthy volunteers may be eligible.
You may be able to join if
- be able to provide written informed consent
- be 19 years of age or older
- having or not having a diagnosis of peripheral artery disease
You likely can't join if
- having a current or pervious aortic aneurysm with or without previous intervention
- having previous revascularization surgeries (open or endovascular) of the legs or aorta
- having walking impairments independent of lower-limb ischemia (e.g., musculoskeletal injury)
- having gangrene or ulcers of the toes/feet
- being currently pregnant or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Omaha, Nebraska, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Omaha, Nebraska, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.